Donor derived cell free Deoxyribonucleic acid (DNA) testing
Veterans Affairs · 247-NETWORK CONTRACT OFFICE 7 (36C247)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24726Q0623-1 in this department, oldest first.
- Aug 18, 2026 · this noticeSolicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
Who won similar work
6 award notices on SAM.gov in the last 24 months. Matched by: Same office (247-NETWORK CONTRACT OFFICE 7 (36C247)), same product/service code (PSC) Q301.
Single-winner award sizes (6): middle half $413K to $5.1M, median $662K; range $365K to $46.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED · $DGX · $9.3B | 2 | $52.6M | Jul 6, 2026 |
| ROCHE DIAGNOSTICS CORPORATION | 1 | $795K | Nov 13, 2025 |
| CAREFUSION SOLUTIONS, LLC · $BDX · $19.4B | 1 | $529K | Apr 14, 2025 |
| SYSMEX AMERICA, INC | 1 | $374K | May 29, 2026 |
| WINERGY LLC | 1 | $365K | Jun 17, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $DGX reported $9.3B revenue in FY2025. The median single-winner award in these 6 past awards, $662K, is under 0.1% of that. 10-K
- $BDX reported $19.4B revenue in FY2025. The median single-winner award in these 6 past awards, $662K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Jul 6, 2026QUEST DIAGNOSTICS INCORPORATED$46.0MQ301--FY24: VISN7-Reference Lab -Base + 4 Option Yrs.Materiality: 0.50% of $DGX revenue (Low) SEC
- May 29, 2026SYSMEX AMERICA, INC$374K679 Urinalysis CPRNo listed company matched (Materiality N/A)
- Mar 24, 2026QUEST DIAGNOSTICS INCORPORATED$6.6MVISN 7 REF LAB BRIDGE 5 MONTH +2 MONTH OPTMateriality: 0.07% of $DGX revenue (Low) SEC
- Nov 13, 2025ROCHE DIAGNOSTICS CORPORATION$795KAUTOMATED TISSUE STAINING ANALYZERS (CPK) - COLUMBIA VAMCNo listed company matched (Materiality N/A)
- Jun 17, 2025WINERGY LLC$365KPharmacy Microbiology Testing | Base plus 4 Option YearsNo listed company matched (Materiality N/A)
- Apr 14, 2025CAREFUSION SOLUTIONS, LLC$529KQ301--Award Notice BD Profiling for Pyxis ES Med StationsMateriality: <0.01% of $BDX revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $46K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.